找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends; Mark A. Giembycz,Brian J. O’Connor Book 2000 Springer Basel AG 2000 Atm

[复制链接]
楼主: 决绝
发表于 2025-3-25 04:56:39 | 显示全部楼层
Wilhelm Magnus,Fritz Oberhettinger at that time described benefit in chronic asthma [4], demonstrating the unequivocal benefit of corticosteroids in asthma. Subsequently, both oral and inhaled corticosteroids have evolved into the most important and useful drugs currently available to treat asthma
发表于 2025-3-25 11:09:21 | 显示全部楼层
发表于 2025-3-25 13:14:33 | 显示全部楼层
发表于 2025-3-25 19:34:41 | 显示全部楼层
Wilhelm Magnus,Fritz OberhettingerWith the increasing awareness of the importance of inflammation in the pathogenesis of asthma even in relatively mild patients [1], more and more emphasis is being put on anti-inflammatory approaches to treatment.
发表于 2025-3-25 22:36:46 | 显示全部楼层
发表于 2025-3-26 03:38:38 | 显示全部楼层
发表于 2025-3-26 06:05:15 | 显示全部楼层
Steroid Sparing Therapies in Asthma,The recognition that asthma is a consequence of airway inflammation has focused treatment goals towards anti-inflammatory agents. Inhaled and systemic corticosteroids are of proven benefit and inhaled steroids are so effective that systemic corticosteroids are usually reserved for acute exacerbations of the condition.
发表于 2025-3-26 11:19:34 | 显示全部楼层
发表于 2025-3-26 13:21:04 | 显示全部楼层
https://doi.org/10.1007/978-3-663-12119-0accepted epidemiological definition of the condition. Existing definitions of asthma in adults are more descriptive than definitive, focussing on the clinical characteristics of reversible airways obstruction, chronic airway inflammation, and increased bronchial responsiveness to a variety of stimul
发表于 2025-3-26 18:44:53 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-6 12:25
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表